Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2018-07-03 Environmental & Social …
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
关于补充披露年度报告环境保护相关情况的公告
Environmental & Social Information Classification · 95% confidence The document is a supplementary disclosure related to the environmental protection section of the company's 2017 Annual Report. It references the original 2017 Annual Report disclosed on April 28, 2018, and provides detailed additional information on environmental protection matters such as pollution emissions, treatment facilities, environmental permits, emergency plans, and monitoring results. The document explicitly states it is a supplement to the 2017 Annual Report and does not affect the financial status or operating results. It is not the full Annual Report itself but an additional disclosure focusing on environmental and social responsibility aspects. Given the detailed environmental data and the nature of the disclosure, this fits best under Environmental & Social Information (SR). The document length (over 11,000 characters) and content confirm it is a substantive report, not a mere announcement or certification. Therefore, the classification is SR with high confidence.
2018-07-03 Chinese
2017年年度报告（更新后）
Annual Report Classification · 100% confidence The document is titled as the "2017 年年度报告全文" which translates to "2017 Annual Report Full Text" for 华邦生命健康股份有限公司 (Huapont Life Sciences Co., Ltd.). It contains detailed sections typical of an annual report, including company overview, financial data, management discussion and analysis, business overview, and financial statements. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of audited financial data, management statements, and comprehensive business descriptions confirms it is the official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K). FY 2017
2018-07-03 Chinese
关于回购股份比例达1%暨回购进展公告
Transaction in Own Shares Classification · 100% confidence The document is a public announcement from Huabang Life Health Co., Ltd. regarding the progress of its share repurchase program. It details the number of shares repurchased, the percentage of total share capital repurchased (exceeding 1%), transaction prices, and total payment amount. The document references regulatory requirements for disclosure of share repurchase progress and the obligation to announce when repurchases exceed 1% of total shares. The content is focused on the company's buyback activity and does not contain financial statements or earnings data. The document length is short (1002 characters) and is a progress announcement rather than a full financial report. Therefore, it fits the category of Transaction in Own Shares (POS).
2018-07-02 Chinese
2014年公司债券（第一期）受托管理事务报告（2017年度）
Audit Report / Information Classification · 95% confidence The document is titled as a "2017年度受托管理事务报告" (2017 Annual Trustee Management Report) for a corporate bond issued by Huapont Life Sciences Co., Ltd. It contains detailed financial data for the year 2017, including operating income, profit, balance sheet, cash flow, bond issuance details, bondholder meeting information, credit rating updates, and compliance with bond covenants. The document is comprehensive and includes substantive financial statements and analysis for a specific fiscal year, but it is focused on the bond issuance and trustee management rather than the company's full annual report. This type of report is a standalone audit/management report related to bond issuance and trustee duties, not a full annual report (10-K) or interim report. It is not a simple announcement or certification but a detailed report on bond management and financial status. Therefore, the most appropriate classification is Audit Report / Information (AR). The document length (9807 characters) supports it being a full report rather than a brief announcement. FY 2017
2018-06-29 Chinese
2015年公司债券受托管理事务报告（2017年度）
Audit Report / Information Classification · 95% confidence The document is titled as a "2015年公司债券受托管理事务报告（2017年度）" which translates to "2015 Company Bond Trustee Management Affairs Report (2017 Annual)". It is issued by the bond trustee (西南证券股份有限公司) and contains detailed information about the bond issuance, the issuer's 2017 operating and financial status, use of raised funds, debt repayment measures, bondholder meetings, bond interest and principal payments, credit rating updates, and trustee duties. The document includes financial data and operational details specifically related to the bond and its management for the year 2017. It is not a full annual report of the company, nor is it a simple announcement or certification. It is a specialized report focused on bond trustee management affairs, which fits the category of an Audit Report / Information (AR) as it relates to regulatory and trustee reporting on bond issuance and management, including financial and operational compliance. The document length (9811 characters) and content depth confirm it is a full report, not just an announcement. Therefore, the appropriate classification is AR (Audit Report / Information). FY 2017
2018-06-29 Chinese
董事会战略委员会工作细则（2018年6月）
Governance Information Classification · 100% confidence The document is titled as the 'Board of Directors Strategic Committee Work Rules' of a company, detailing the structure, responsibilities, and procedures of the board's strategic committee. It is a governance-related document outlining internal rules and committee operations rather than financial results, audit information, or announcements. There is no indication of financial data, voting results, or regulatory filings. The content fits the description of Governance Information, which covers internal rules, board structure, and governance practices.
2018-06-28 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.